Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1-Reference-Cited by-同舟云学术

Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1

Published:2020-07-23 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Wu Di,Liu Yangyang,Li Xiaoting,Liu Yiying,Yang Qifan,Liu Yuting,Wu Jingjing,Tian Chen,Zeng Yulan,Zhao Zhikun,Xiao Yajie,Gu Feifei,Zhang Kai,Hu Yue,Liu Li

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin.,2019

2. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med.,2009

3. Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer;Kwak;N Engl J Med.,2010

4. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey;Yatabe;J Thorac Oncol.,2015

5. Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer;Tan;Lancet Oncol.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy;Future Oncology;2024-08-05

2. Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy;Frontiers in Immunology;2024-03-08

3. Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response;Cancers;2023-11-28

4. At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC;Nature Reviews Clinical Oncology;2023-01-13

5. Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia;Experimental Hematology & Oncology;2022-11-16